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1. Introduction 
Periodontal diseases are inflammatory diseases of the supporting structures of the teeth 
(Cochran, 2008; Kornman, 2008). They are initiated by periodontopathic bacteria and result 
in progressive destruction and loss of the periodontium (Cochran, 2008; Kornman, 2008). 
Progression of periodontal disease eventually leads to tooth loss (Chambrone, et al., 2010). 
Periodontal diseases are multifactorial with complex pathogenesis (Cochran, 2008; 
Kornman, 2008).  
Plaque bacteria trigger a host inflammatory response in the gingival tissues (Kornman, 
2008). Neutrophils migrate from within the gingival tissues towards the gingival crevice and 
build a barrier wall against the bacteria (Kornman, 2008). Within the gingival connective 
tissue, the gingival macrophages and fibroblasts produce inflammatory cytokines (e.g. 
interleukin-1 and tumor necrosis factor- alpha) that activate collagenases and other 
degrading enzymes (Kornman, 2008). These enzymes when released and activated destroy 
the gingival collagen. Lymphocytes are recruited to the gingival lesion to initiate an 
adaptive immune response and help with containing the infection (Kornman, 2008). With 
persistence of the microbial infection, the inflammatory changes in the gingival tissues 
expand apically and reach the alveolar bone (Cochran, 2008). Inflammatory mediators such 
as interleukin-1, interleukin-6, tumor necrosis factor alpha and prostaglandins induce 
osteoclasogenesis (Cochran, 2008). Increased inflammatory activity disrupts the normal 
balance of bone formation/resorption and results in alveolar bone loss (Cochran, 2008).  
Periodontal disease is a serious and morbid oral condition among Down-syndrome (DS) 
affected individuals (Morgan, 2007). Gingivitis and periodontitis start early in life and their 
severity increases with age (Reuland-Bosma, et al., 1988). Periodontal disease advances rapidly 
in DS individuals and is characterized by severe gingival inflammation, loss of periodontal 
attachment and radiographic alveolar bone loss (Agholme, et al., 1999; Saxen, et al., 1977). 
Heavy amounts of plaque and calculus are often present (Morgan, 2007). Periodontal disease is 
an important cause of tooth loss among DS individuals (Reuland-Bosma, et al., 2001). 
The exact reason (or reasons) for this increased susceptibility to periodontitis is (are) not 
known. Understanding the pathogenesis of periodontitis in DS individuals would greatly 
help with the management and control of the destructive process associated with the disease 
and help DS affected individuals retain their teeth hopefully throughout their lifetime. 
Previously researchers have investigated factors usually associated with periodontitis such as 
subgingival plaque microbial composition, immune and inflammatory responses individually 
in DS affected individuals. The individual factors investigated were never collectively 
evaluated together to provide an overall understanding of the pathogenesis of periodontitis in 
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individuals with DS. The objective of this chapter is to review in a systematic fashion all the 
involved factors previously reported together to generate a hypothetical collective model of the 
pathogenesis of periodontal disease in individuals with DS. Such a model would enhance our 
understanding of periodontal disease development/progression in this vulnerable group, 
would help with disease management, would identify gaps in knowledge, and would provide 
enlightenment for future research endeavors.  
In this review I have searched the available dental/medical literature for studies 
investigating the main factors suspected in the increased susceptibility to periodontitis in DS 
individuals. I have summarized the main findings from these studies and used this 
information to generate a hypothetical model of the pathogenesis of periodontitis in DS 
individuals. 
2. Methods 
The methodology applied in this review covers the literature search strategy, inclusion and 
exclusion criteria for choosing articles, screening of articles and quality assessment of the 
selected articles. 
2.1 Search strategy 
Electronic searching was performed using the following databases: MEDLINE (1948-2011) 
and PubMed. The search terms that were used related to the subject groups of interest: 
Down syndrome and mental retardation; the oral condition: gingivitis, periodontitis, 
periodontal disease, gingiva, periodontium, tooth loss; etiological factors: microbiological 
(dental plaque, subgingival plaque, periodontopathic bacteria), immune factors 
(neutrophils, lymphocytes, antibody production) and inflammatory factors (cytokines, 
prostaglandins, metalloproteinases) and the type of study: comparative study, randomized 
controlled trial, or review. The search was limited to English language literature. The 
electronic search was supplemented by checking bibliographies of review papers. One 
hundred forty five articles were initially identified.  
2.2 Inclusion criteria 
Studies were included if they met the following minimum criteria: 
1. Human subjects with Down syndrome. 
2. Clinical measures of periodontal status. 
3. Microbiological, immune or inflammatory measures. 
4. Comparison of DS subjects to a control/comparison group(s). 
5. Written in English. 
2.3 Exclusion criteria 
Editorial letters, historical reviews and descriptive studies such as case reports were 
excluded. In addition, studies that did not specifically address the main focus of the search 
or duplicated other studies were also excluded. 
2.4 Screening and selection of papers 
At first the articles were screened by title and abstract. A review of abstracts based on the 
criteria above led to initial consideration of 32 articles. Then full text was retrieved either 
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electronically or in printed format. Further review of full texts resulted in inclusion of 20 
articles.  
2.5 Quality assessment 
Systematic reviews need to assess the methodological quality of the included studies (Pai, et 
al., 2004). Quality within the context of this chapter refers to the minimization of bias. An 
objective of this assessment was to judge the strength of the scientific evidence with higher 
score given to studies free of bias. To minimize bias, the comparison group needs to be 
matched as close as possible to the DS group. In addition, the evaluated parameters should 
be assessed in the same manner between the groups. Studies with an adequately matched 
control group were scored higher than studies that used population data or previously 
collected data for comparison. 
The instrument used for judging articles for this chapter was based freely on the use of 
STROBE methodology (von Elm, et al., 2007) evaluating the following parameters: 
 Down syndrome diagnosis: clearly stated and explained. 
 Inclusion of a comparison group: well matched (age, gender, race) or not. 
 Periodontal parameters: how periodontitis was defined and measured. Adequate if 
clinical attachment level was reported. Inadequate when only periodontal probing 
depth or radiographic measurements are reported. 
 Laboratory methodology to assess microbial, immune or inflammatory factors: was the 
methodology clearly explained. Was the methodology appropriate or not. 
 Examiner calibration: adequate if reported, inadequate if not reported. 
 Descriptive information: characteristics of study participants (number of subjects, 
gender, mean and range of age) were clearly presented. 
 Confounders identified: confounders that may affect periodontal status such as age, 
gender, and plaque levels were clearly defined. 
 Data analysis: adequate when multivariate analysis adjusting for confounders was 
presented. Inadequate if only bivariate analysis was presented. 
The studies included in the review were scored as follows: 
 Score 1: when all the parameters presented above were reported in the study. 
 Score 2: when only DS diagnosis, inclusion of a comparison group, clinical periodontal 
measures and laboratory measures were reported. 
 Score 3: other than score 1 and 2. 
3. Results 
A total of 20 articles were selected, 5 articles related to microbiological evaluations, 3 articles 
related to neutrophil function, 3 articles related to gingival cellular immunity, 4 articles 
related to antibody production and 5 articles related to degrading enzymes and 
inflammatory mediators. All selected articles met the minimum inclusion criteria previously 
described. Two articles were scored as 1, fifteen articles were scored as 2 and three articles 
were scored as 3. 
Nineteen out of the twenty selected studies were designed as cross-sectional case-controlled 
studies. Thus in addition to the DS group, they included a matched comparison group of 
either medically healthy and periodontally healthy individuals or a comparison group with 
mental disability other than DS. One study was longitudinal (Zaldivar-Chiapa, et al., 2005).  
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Fig. 1. Summary of search strategy. 
Down subjects in most of the studies were either children or young adults. Few of the 
selected studies included DS adults (Amano, et al., 2001; Chaushu, et al., 2007; Komatsu, et 
al., 2001; Sakellari, et al., 2005; Sohoel, et al., 1995).  
3.1 Summary of study methodologies 
Microbiology studies employed a variety of techniques including culturing, polymerase 
chain reaction and checkerboard DND-DNA hybridization techniques to investigate the 
composition of subgingival plaque. All the studies attempted to compare the subgingival 
plaque composition of DS individuals to a matched comparison group. In addition some 
studies attempted to determine at what age important periodontopathic bacteria become 
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detectable in DS individuals. A few studies attempted to investigate the association between 
presence of periodontopathic bacteria and clinical periodontal parameters in DS individuals. 
Neutrophil function studies mainly focused on neutrophil chemotaxis. Neutrophil 
chemotaxis was measured by the Boyden chamber method. All selected studies compared 
neutrophil chemotaxis of DS individuals to a matched comparison group. One of the studies 
investigated the relation between neutrophil chemotaxis measures with clinical and 
radiographic periodontal measures. 
Gingival cellular immunity studies examined the immune cellular composition, expression 
of HLA Class II antigens on the surfaces of immune cells and gamma/delta T-cell receptor-
bearing lymphocytes in discarded gingival tissues from DS individuals. Indirect 
immunofluorescent techniques were used to examine the gingival tissues. All the selected 
studies compared the gingival tissue cellular findings in DS individuals to medically and 
periodontally healthy individuals. 
The selected antibody production studies focused on specific antibodies against some 
important periodontopathic bacteria. The studies examined either serum antibody titers or 
salivary antibody levels. All selected studies used an enzyme-linked immunosorbent assay 
(ELISA). Four of the selected studies compared the antibody serum titer or saliva levels in 
DS individuals to matched controls. One study made the comparison to a normal adult 
reference serum pool. 
The selected studies investigating degrading enzymes and inflammatory mediators mainly 
focused on matrix metalloproteinases (MMP) activity in gingival fluid. One study examined 
cultured fibroblast MMP activity. Two studies examined prostaglandin E2 (PGE2) and one 
study examined interleukin-1 (IL-1) in gingival fluid. All selected studies compared their 
findings in DS individuals with non-DS controls. MMP activity was assessed with a variety 
of techniques including gel electrophoresis, Western blot analysis and ELISA. PGE2 was 
assessed with a radio-immuno-assay and IL-1 with ELISA. 
3.2 Summary of study findings 
A summary of all selected articles and their main findings is presented in the following 
tables: 
3.2.1 Subgingival plaque composition studies 
 
Author Scr. DS  CG Measures Findings 
Barr-
Agholme 
1992 
2 37 37 Levels of Aggregatibacter 
(Actinobacillus) 
actinomycetemcomitans, 
Capnocytophaga and 
Porphyromonas gingivalis 
were determined in 
subgingival plaque 
samples. 
A. actinomycetemcomitans was 
detected in the subgingival 
plaque in 35% of the DS 
adolescents and in 5% of the 
controls. On site level, A. 
actinomycetemcomitans and 
Capnocytophaga were more 
frequent in the subgingival 
plaque samples of DS children 
than in those of controls. 
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Author Scr. DS  CG Measures Findings 
Amano 
2000 
2 
 
60 
Yng.
60 Ten periodontal pathogens 
were surveyed in 
subgingival plaque samples 
using a polymerase chain 
reaction. 
All of the pathogens were 
detected with greater frequency 
in the DS children. Tannerella 
forsythia (Bacteroides forsythus), 
Treponema denticola, Prevotella 
nigrescens, and Campylobacter 
rectus were significantly 
prevalent throughout all age 
brackets of the DS children. The 
occurrence of Porphyromonas 
gingivalis was also significant in 
the DS subjects over 5 years old. 
Amano 
2001 
2 67 
Adt.
41 Ten periodontal pathogens 
were surveyed in 
subgingival plaque samples 
using a polymerase chain 
reaction. 
No significant differences were 
observed in the bacterial profiles 
between the two groups. 
Sakellari 
2005 
1 70
 
121
NC 
 
76  
MR 
Clinical parameters and 
microbiological analysis by 
“checkerboard” DNA-DNA 
hybridization. 
Important periodontal pathogens 
including Porphyromonas 
gingivalis, Tannerella forsythia 
(Bacteroides forsythus) and A. 
actinomycetemcomitans colonize 
these subjects earlier and at 
higher levels. 
Reuland-
Bosma 
2001 
2 17 17 Prevalence and proportions 
of the putative periodontal 
pathogens A. 
actinomycetemcomitans, 
Porphyromonas gingivalis, 
Prevotella intermedia, 
Tannerella forsythia 
(Bacteroides forsythus), 
Peptostreptococcus micros, 
Fusobacterium nucleatum and 
Campylobacter rectus in the 
subgingival plaque were 
determined using anaerobic 
culture techniques. 
No differences in the prevalence 
of distinct suspected 
periodontopathic bacteria and 
bacterial subgingival 
composition between the DS 
group and the comparison group 
could be established. 
Scr = score, DS = number of DS group, CG = number of comparison group, Yng = young, Adt = adult, 
NC = normal controls, MR = mental retardation not Down. 
Table 1. Summarizes the findings of the subgingival plaque composition studies.  
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3.2.2 Neutrophil function studies 
 
Author Scr. DS  CG Measures Findings 
Izumi 
1989 
2 14 14 Periodontal clinical 
measures, radiographic 
measures and 
neutrophil chemotaxis. 
DS patients showed significantly 
lower chemotaxis than healthy 
volunteers. Bone loss in DS subjects 
was inversely proportional to the 
chemotactic index. 
Yavuzyilm-
az 
1993 
2 15 15 Clinical periodontal 
parameters, chemotaxis 
and random migration 
of neutrophils. 
The random migration and 
chemotaxis of neutrophils from DS 
subjects were significantly 
decreased in comparison with the 
control group. 
Zaldivar-
Chiapa 
2005 
Longitudinal 
2 14 
 
9 Clinical parameters and 
neutrophil function. 
Neutrophil chemotaxis, phagocytic 
activity, and production of super-
oxide anion were significantly 
decreased in the DS patients. 
Scr = score, DS = number of DS group, CG = number of comparison group. 
Table 2. Summarizes the neutrophil function studies.  
3.2.3 Gingival immune response studies 
 
Author Scr. DS CG Measures Findings 
Sohoel 
1992 
3 16 12 Indirect immune-
fluorescence used 
to study immune 
cellular 
composition of 
gingival tissues 
from DS 
individuals. 
Denser inflammatory infiltrate in DS 
individuals. Counting showed 
different cell distribution and cell 
profiles between DS subjects and non-
DS subjects. 
Sohoel 
1995 
3 16 14 Expression of 
HLA Class II 
antigens on the 
surfaces of 
immune cells. 
Increased frequency of HLA Class II 
(HLA-expression on inflammatory 
cells and on keratinocytes of the oral 
gingival epithelium) in chronic 
periodontitis of DS patients compared 
to sections from non-DS subjects. 
Sohoel 
1995 
3 NR NR Assessment of 
Gamma/delta T-
cell receptor-
bearing 
lymphocytes in 
gingival tissues. 
Gamma/delta T-cell receptor-bearing 
lymphocytes are decreased in inflamed 
gingival tissues of DS individuals. 
Scr = score, DS = number of DS group, CG = number of comparison group, NR = not reported. 
Table 3. Summarizes the gingival immune cellular response studies. 
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3.2.4 Antibody production studies 
 
Author Scr. DS  CG Measures Findings 
Santos 
1996 
2 16  
 
10 Circulating antibody 
titers to A. 
actinomycetemcomitans
. 
Significant differences were noted 
between the control group and the DS 
subjects (p = 0.05), with the DS 
periodontitis group having the highest 
response, followed by the DS gingivitis 
group and normal controls, respectively. 
The DS groups were not significantly 
different.
Morinushi 
1997 
3 75 
 
RSP Antibody titers to 
Porphyromonas 
gingivalis (Pg), 
Prevotella intermedia 
(Pi), Treponema 
denticola (Td), 
Fusobacterium 
nucleatum (Fn), 
Selenomonas sputigena 
(Sel), A. 
actinomycetemcomitans 
(Aa), and 
Streptococcus mitis 
(Mi).
IgG antibody titers to Pg, Aa, Sel, and Mi 
increased significantly with increasing 
gingival inflammtion score. Furthermore, 
the IgG antibody titers to Pg were higher 
(P < 0.05) in the most extensive disease 
group compared to the DS no-disease 
group. The IgG antibody titers to Pg at 
early puberty were significantly higher 
when compared to preschool children. 
Barr-
Agholme 
1998 
2 20 19 Salivary levels of 
immunoglobulins 
sIgA, IgM, and IgG 
subclass distribution 
and albumin, 
quantified by 
enzyme-linked 
immunosorbent 
assay. 
The immunoglobulin levels of sIgA, IgM, 
the sum of IgG subclasses, and the 
concentration of albumin did not differ 
significantly between the 2 groups. 
However, the proportion of IgG1 
expressed as percentage of the sum of total 
IgG was significantly higher (P < 0.01) in 
the Down syndrome group compared to 
controls. On the contrary, the proportion 
of IgG2, IgG3, and IgG4 subclasses in 
saliva did not differ between the 2 groups. 
Chaushu 
2007 
2 40 
 
39 
 
The levels of total 
IgA, and specific 
antibodies to three 
common oral 
pathogens 
(Porphyromonas 
gingivalis, 
Actinobacillus 
(Aggregatibacter) 
actinomycetemcomitans 
and Streptococcus 
mutans) were 
analyzed.
The median secretion rates of the specific 
antibodies in whole and parotid saliva 
were 70-77% and 34-60% (respectively) 
lower in young DS individuals as 
compared to young controls and farther 
77-100% and 75-88% (respectively) lower 
in old DS compared to young DS. 
Scr = score, DS = number of DS group, CG = number of comparison group, RSP = reference serum pool. 
Table 4. Summarizes the antibody production studies.  
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3.2.5 Inflammatory mediator studies 
 
Author Scr. DS CG Measures Findings 
Halinen 
1996 
2 9  9 Clinical periodontal 
measures and 
matrix 
metalloproteinase 
(MMP-8 and -9) 
activities in saliva 
and in gingival 
crevicular fluid. 
The endogenously active collagenase and total 
collagenase activities were slightly higher in 
GCF of DS children compared to healthy 
controls. GCF collagenase of DS patients was 
human neutrophil collagenase (MMP-8 or 
collagenase-2), in DS patients, but not in 
controls. Salivary collagenase in DS was high 
when compared to controls but of the same 
MMP-8 type as in control saliva.  
Barr-Agholme 
1997 
2 15 15 Levels of 
prostaglandin E2 
(PGE2) and 
interleukin-1 beta 
(IL-1 beta) were 
determined in 
gingival crevicular 
fluid. 
The mean level of PGE2 in GCF was 
significantly higher (P < 0.05) in the Down 
syndrome group than in the control group. In 
GCF samples collected from sites 
characterized as non-inflamed, the mean level 
of PGE2 was significantly higher (P < 0.001) in 
the Down syndrome group than in the 
controls. The mean level of PGE2 in samples 
from inflamed sites, on the other hand, did 
not differ between the two groups. The mean 
level of IL-1 beta was not significantly higher 
in the Down syndrome group than in the 
controls.
Komatsu 
2001 
2 9 9 Enzyme activity 
and the mRNA 
expression pattern 
of matrix 
metalloproteinases 
(MMPs) of cultured 
gingival fibroblasts 
(GF) and fresh 
gingival tissues.
The production of the active type of MMP-2 in 
GF from Down's syndrome patients (D-GF) 
was found to be significantly higher (P < 0.05) 
than that of the control GF (C-GF) at the 
protein level. 
Tsilingaridis 
2003 
2 18 14 Levels of 
prostaglandin E2 
(PGE2), leukotriene 
B4 (LTB4), and 
matrix 
metalloproteinase-9 
(MMP-9) in 
gingival crevicular 
fluid.
The mean levels of PGE2, LTB4, and MMP-9 
were significantly (P<0.05) higher in GCF 
from Down syndrome patients compared to 
controls. 
Yamazaki-
Kubota 
2010 
1 14 14 Matrix 
metalloproteinase 
(MMP-8 and MMP-
2) activity in 
gingival crevicular 
fluid.
Levels of MMP-2 and MMP-8 in Down's 
syndrome patients were higher than those in 
healthy control subjects. 
Scr = score, DS = number of DS group, CG = number of comparison group. 
Table 5. Summarizes the inflammatory mediator studies. 
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4. Discussion 
Periodontal disease is a common problem among DS individuals with an estimated 
prevalence between 58% and 96% for those under 35 years of age (Morgan, 2007). The 
disease starts early in life and progresses with age eventually leading to tooth loss (Reuland-
Bosma, et al., 2001; Saxen, et al., 1977; Saxen & Aula, 1982). Periodontal disease in DS 
individuals adversely impacts on the quality of their life (Amaral Loureiro, et al., 2007). The 
increased prevalence and severity of periodontal disease in DS individuals inspired many 
researchers to investigate the various factors that might be involved. 
Periodontal diseases are initiated by bacterial plaque build-up in the dentogingival region 
(Kornman, 2008). It is well documented that DS individuals have difficulty with maintaining 
adequate oral hygiene levels and thus tend to harbor high levels of bacterial plaque on their 
teeth (Cohen, et al., 1961; Khocht, et al., 2010; Sakellari, et al., 2005). In addition, DS 
individuals following oral hygiene instructions have reduced ability to master adequate 
plaque control (Sakellari, et al., 2001). It was often surmised that mental disability associated 
with DS is an important factor in their reduced ability to maintain adequate oral hygiene 
and consequently increases their susceptibility to periodontitis (Desai, 1997; Morgan, 2007). 
Our group (Khocht, et al., 2010) recently showed in a multivariate model including 
traditional risk factors for periodontitis combined with mental disability that loss of 
periodontal attachment in DS individuals was not associated with mental disability. Thus 
other factors associated with DS might be involved.  
It is well documented that DS is associated with immune deficiencies and host response 
impairment (Kusters, et al., 2009; Reuland-Bosma, et al., 1988). Infections, in particular 
respiratory infections are an important cause of death in DS individuals (Thase, 1982). The 
most likely reason for this increased susceptibility to infection and reduced immunity in DS 
individuals is an increased dosage of a protein product or products encoded by 
chromosome 21. Several proteins important in immune function are encoded on 
chromosome 21. Examples include superoxide dismutase (SOD), carbonyl reductase 
(NADPH) (Lemieux, et al., 1993) and integrin beta-2 (CD18). Increased SOD and NADPH 
production is associated with increased oxidative stress and tissue injury in DS individuals 
(Akinci, et al., 2010; Strydom, et al., 2009). Aberrant expression of CD18 integrin on immune 
cell surfaces in DS individuals may be associated with altered lymphocyte function (Kusters, 
et al., 2009; Taylor, 1987). The IL10RB component of the IL-10 receptor (involved with 
resolution of inflammation) is encoded by chromosome 21 and its function may be altered in 
DS individuals (Glocker, et al., 2009). In addition, it seems that interleukin-1 (IL-1) is 
upregulated indirectly by some chromosome 21 based genes (Mrak & Griffin, 2004). IL-1 is 
an important immune/inflammatory mediator. Its increased production in DS individuals 
was associated with brain tissue damage (Mrak & Griffin, 2004). 
Since periodontitis is initiated by bacterial infections, indeed it is conceivable that altered 
immunity in DS individuals may be the primary reason for their increased susceptibility to 
periodontal infections. Perhaps reduced immunity in DS individuals would make it easier 
for virulent periodontopathic microbial species to colonize their subgingival plaque. If true, 
such elevated microbial presence, unchallenged and unchecked, would induce an intense 
inflammatory reaction within the gingival tissues. Increased gingival inflammation within 
the gingival tissues would lead to elevated production of degrading enzymes and alter bone 
remodeling. The end result of these inflammatory induced changes would be the loss and 
destruction of the periodontium and eventually tooth loss. Several studies (microbiological, 
immune and inflammatory) attempted to investigate these hypotheses.  
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Fig. 2. The above schematic illustrates the main findings of the selected articles. Decreased 
salivary flow and associated decreased salivary antibody production. Neutrophils with 
defective chemotaxis incapable of reaching the target pathogens. Early colonization of the 
dentogingival region with periodntopathic bacteria. Gingival marginal tissues heavily 
infiltrated with immune cells such as macrophages and lymphocytes. Antigen presenting 
cells active in processing and presenting microbial antigens. Robust humoral antibody 
production. Macrophages and other gingival cells engaged in producing degrading 
enzymes (MMPs). Collagen degradation. Tissue injury and release of prostaglandins 
(PGE2). Increased osteoclastic activity and alveolar bone loss. 
4.1 Microbiological studies 
Barr-Agholme et al. (1992) reported increased presence of Aggregatibacter (Actinobacillus) 
actinomycetemcomitans, Capnocytophaga and Porphyromonas gingivalis in subgingival plaque of 
adolescents with DS. A. Actinomycetemcomitans was detected in 35% of patients with DS 
compared to 5% in the healthy, age and sex matched controls. The authors suggested that 
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this increased frequency of A. actinomycetemcomitans indicated an altered microbial 
composition in the subgingival plaque of DS patients as compared to healthy controls. 
Amano et al. (2000) found various periodontal disease-causing bacteria present in very young 
DS patients. The authors reported that various periodontopathic bacteria could colonize the 
teeth in the very early childhood of DS patients. Pathogens in DS patient’s subgingival 
plaque were detected with far greater frequency than in the age-matched controls. This may 
be the reason why these DS patients have such intense gingival inflammation. The authors 
concluded that periodontopathic pathogens establish a presence at a very early age, and that 
certain bacteria, like P. gingivalis, play a key role in the initiation of gingival inflammation. 
Sakellari et al. (2005) evaluated seventy DS patients, 121 age-matched healthy individuals 
and 76 patients with cerebral palsy. Full-mouth recordings of clinical periodontal 
parameters were assessed and subgingival plaque samples were taken from the Ramfjord 
teeth and analysed for 14 species using "checkerboard" DNA-DNA hybridization. They 
reported that important periodontal pathogens colonize these subjects earlier and at higher 
levels compared with age-matched healthy individuals and patients with cerebral palsy. 
Reuland-Bosma et al. (2001) compared subgingival microflora in DS adult patients to other 
mentally retarded individuals. Despite advanced periodontitis in DS patients, no differences 
in the prevalence of distinct suspected periodontopathic bacteria were established between 
the DS patients and the control group. The authors concluded that host factors are the most 
likely explanation for the advanced periodontal disease associated with DS patients. 
Amano et al. (2001) took subgingival plaque specimens from 67 DS young adults and 41 
age-matched systemically healthy individuals with mental disabilities (MD). The prevalence 
of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Bacteroides forsythus, 
Treponema denticola, Prevotella intermedia, Prevotella nigrescens, Capnocytophaga ochracea, 
Capnocytophaga sputigena, Campylobacter rectus, and Eikenella corrodens, were investigated in 
subgingival plaque samples using a polymerase chain reaction method. The authors found 
no significant differences in the bacterial profiles between the groups.  
The cited microbiological studies indicate early colonization of important periodontal 
pathogens in children and adolescents with DS. However, the microbial subgingival profile 
of adult DS individuals is not different from matched non-DS individuals. Perhaps reduced 
immunity in young DS individuals facilitates early colonization in comparison to young 
non-DS individuals with normal immunity. With age, and a combination of long-term 
exposure to pathogens and changes in immune response, non-DS individuals may also be 
susceptible to colonization by periodontal pathogens. However, despite lack of differences 
in microbial profiles between adult DS and non-DS individuals, adult DS individuals still 
show greater loss of periodontal attachment (Amano, et al., 2001; Reuland-Bosma, et al., 
2001). This suggests that the host response to the same bacteria is different between DS and 
non-DS individuals. It seems that the immune-inflammatory response in DS is more intense 
resulting in greater tissue damage. The following studies will investigate this claim. 
4.2 Immune dysfunction studies 
As we said earlier, DS is associated with immune dysfunction (Kusters, et al., 2009). Various 
studies investigated different components of the immune system in relation to periodontitis 
in DS patients. These studies mainly focused on neutrophil function, the gingival immune 
cellular response and antibody production against periodontopathic bacteria. 
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4.2.1 Neutrophil function studies 
Izumi et al. (1989) found a faulty neutrophil chemotaxis in DS patients. The authors reported 
that DS patients had significantly lower chemotaxis compared to healthy controls.  Since the 
neutrophils are the main cells involved in the first line of host defense in a bacterial 
invasion, having a defective neutrophil chemotaxis can lead to the progression of 
periodontitis. Significant correlations were identified between the amount of bone loss and 
the age and chemotactic index of the DS patients.  The authors found that the rate of 
periodontal destruction was dependent on the degree of defective chemotaxis.  
Yavuzyilmaz et al. (1993) evaluated clinical parameters, chemotaxis and random migration 
of neutrophils in 15 patients with DS and 15 healthy subjects. Signs of more severe gingival 
inflammation were present in the DS group. The random migration and chemotaxis of 
neutrophils were significantly decreased in comparison with the control group. 
Zaldivar-Chiapa (2005) examined patients with DS to evaluate the effectiveness of surgical 
and non-surgical periodontal therapies and to assess their neutrophil immunological status. 
The population consisted of 14 DS patients, 14 to 30 years old. Surgical and non-surgical 
periodontal therapies were compared in a split-mouth design. Clinical periodontal 
parameters were recorded at baseline, post-treatment, 6 months, and 1 year. Neutrophil 
chemotaxis, phagocytic activity, and production of super-oxide anion were compared 
between DS patients and healthy controls. Both surgical and non-surgical therapies showed 
a significant improvement in all the clinical parameters compared to baseline. Neutrophil 
chemotaxis, phagocytic activity, and production of super-oxide anion were significantly 
decreased in the DS patients. The authors concluded that the neutrophil impairment does 
not seem to affect the clinical response to therapy. 
All the presented studies showed deficient neutrophil chemotaxis in DS subjects. The reason 
for impaired neutrophil chemotaxis in DS individuals may be secondary to increased 
oxidative stress associated with trisomy of chromosome 21 (Akinci, et al., 2010). Oxidative 
stress may impair internal cell function and disrupt chemotaxis. One study positively 
correlated such reduced chemotaxis with measures of periodontitis (Izumi, et al., 1989). 
Another study gave hope that despite reduced neutrophil chemotaxis, periodontal therapy 
aiming at reducing plaque and correcting periodontal architecture is still helpful (Zaldivar-
Chiapa, et al., 2005).  
4.2.2 Gingival Immune cellular response 
Sohoel et al. (1992) examined the composition of mononuclear cells in the gingival 
inflammatory infiltrate in DS patients with marginal periodontitis. The authors reported 
that DS patients had a higher number of cells in the cellular infiltrate of chronic marginal 
periodontitis (CMP) compared to normal patients.  There were also an increased number of 
CD22+ cells (B lymphocytes), CD3+ cells, CD4+ cells, CD8+ cells, and CD11+ cells 
(macrophages).  There was also a significantly higher CD4+/CD8+ ratio in DS patients 
when compared to the normal controls, which could indicate active tissue destruction.  This 
study concluded that DS patients have a more pronounced and altered gingival cellular 
immune response when compare to controls. 
Sohoel et al. (1995) investigated the expression of HLA class II antigens in chronic marginal 
periodontitis (CMP) in patients with DS. Variations in the expression of HLA class II 
antigens on antigen-presenting cells play an important role in immune regulation. The 
results of this study indicated an increased frequency of HLA class II antigens in the 
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gingival tissues of CMP DS patients when compared to controls. There were significantly 
higher numbers of CD1a+ cells and ratios of HLA-DR+/CD1a+ cells and HLA-DP+/CD1a+ 
cells in the DS group compared to the control group. The authors concluded that there is a 
highly activated immune response in DS patients.  
The same investigators (Sohoel, et al., 1995) also investigated gamma/delta T lymphocytes 
in gingival tissues of DS individuals. The T-cell receptor (TCR) of gamma/delta T 
lymphocytes is different from the alpha/beta TCR. The gamma/delta TCR binds to antigens 
that are intact proteins and antigens that are not presented within class I or class II 
histocompatibility molecules. The gamma/delta T lymphocytes usually reside within 
epithelial tissues and encounter antigens on the surface of epithelial cells. The researchers 
reported that the percentage of gamma/delta T lymphocytes in the gingival tissues of DS 
subjects was less than 1%. 
The presented studies showed an intense presence of a variety of immune cells within the 
gingival tissues of DS patients with periodontitis. Increased production of HLA class II 
antigens on the surfaces of antigen producing cells suggests that the cells are locally 
engaged in specific immune responses. The low presence of gamma/delta T lymphocytes 
may increase the vulnerability to microbial noxious agents.  
4.2.3 Antibody/immunoglobulin production 
These studies investigated specific antibodies against periodontopathic bacteria in serum 
and saliva. 
Santos et al. (1996) determined the circulating antibody titers to Aggregatibacter 
(Actinobacillus) actinomycetemcomitans (Aa) in sera of DS and normal patients. Eleven DS 
patients with periodontitis (pocket depth > 4 mm), five DS patients with gingivitis 
(inflammation and pocket depth < or = 3 mm), and 10 non-DS healthy subjects had blood 
drawn and analyzed for antibody response to Aa. The authors noted significant differences 
between the control group and the DS groups (p = 0.05), with the DS periodontal group 
having the highest response, followed by the DS gingivitis and normal controls, 
respectively. 
Morinushi et al. (1997) obtained sera from 75 DS subjects (aged 2 to 18 years) and their 
gingival health assessed using a modified gingival inflammation index (PMA Index). 
Antibody titers to Porphyromonas gingivalis, Prevotella intermedia, Treponema denticola, 
Fusobacterium nucleatum, Selenomonas sputigena, Actinobacillus actinomycetemcomitans, and 
Streptococcus mitis were determined using a micro-ELISA. The average antibody titers to A. 
actinomycetemcomitans, S. mitis, and F. nucleatum exceeded those of the normal adult 
reference serum pool. In addition, IgG antibody titers to P. gingivalis , A 
actinomycetemcomitans, F. nucleatum, S. sputigena, and S. mitis correlated significantly with the 
modified PMA scores.  
Barr-Agholme et al. (1998) investigated the clinical periodontal conditions and salivary 
immunoglobulins in patients with DS.  The results showed an altered distribution of IgG 
subclasses in saliva, with an increased amount of IgG1 in DS patients compared to 
controls. This is in agreement with other studies that show increased IgG1 in DS patients 
(Kusters, et al., 2009). On the contrary, the proportion of IgG2, IgG3, and IgG4 subclasses 
in saliva did not differ between the 2 groups. Also, in DS patients with bone loss, it was 
noted that they have an increased level of sIgA, compared to those DS patients without 
bone loss. 
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Chaushu et al. (2007) assessed age-related changes in the salivary-specific humoral 
immunity of DS subjects. Parotid and whole saliva were collected from a young group of 
DS, an older group of DS individuals and compared to two age-matched groups of healthy 
volunteers. The levels of total IgA, and specific antibodies to three common oral pathogens 
(Porphyromonas gingivalis, Aggregatibacter (Actinobacillus) actinomycetemcomitans and 
Streptococcus mutans) were analyzed. The median secretion rates of the specific antibodies in 
whole and parotid saliva were 70-77% and 34-60% (respectively) lower in young DS 
individuals as compared to young controls and farther 77-100% and 75-88% (respectively) 
lower in old DS compared to young DS.  
The presented studies were somewhat controversial and indicated different antibody 
responses between saliva and serum in DS individuals. While in saliva the antibody 
response was low in DS individuals, in serum the antibody responses to several 
periodontopathic bacteria were elevated. The low antibody responses in saliva were 
associated with decreased salivary flow in DS individuals. The low salivary antibody 
activity may facilitate the colonization of periodontal pathogens in DS individuals. The 
elevated antibody titers in DS serum corroborate the gingival immune cellular activity 
described previously. It demonstrates that DS individuals despite known immune 
deficiencies are capable of mounting a humoral specific immune response. Such antibodies 
would find their way into the gingival tissues and fluid and help with containing the 
microbial damage. Increased antibody levels in gingival tissues may also accentuate the 
gingival inflammatory response through complement activation. 
4.3 Inflammatory response studies 
Inflammatory response studies focused on inflammatory mediators and degrading enzymes 
in gingival crevicular fluid. 
4.3.1 Studies investigating inflammatory mediators 
Barr-Agholme et al. (1997) investigated the levels of prostaglandin E2 (PGE2) and 
interleukin-1 (IL-1) in gingival crevicular fluid (GCF). GCF was collected from both DS 
patients and healthy controls. They found the mean level of PGE2 in GCF was significantly 
higher in the DS patients as compared to the controls. This finding suggests an alteration in 
arachidonic acid metabolism in DS patients. The mean level of IL-1 in the GCF was not 
significantly higher in the DS patients as compared to the healthy controls. Perhaps the 
reason the IL-1 levels did not differ between the groups, despite the fact that the gingival 
inflammation was more severe in the DS group, may be because PGE2 has been reported to 
down-regulate the production of IL-1 (Kunkel, et al., 1987). This issue has not been 
revisited since and indeed is worthy of further investigation. 
Tsilingaridis et al. (2003) determined the levels of PGE2, LTB4, and MMP-9 in GCF from 18 
Down syndrome patients and from 14 controls matched with respect to age and degree of 
gingival inflammation. Clinical periodontal parameters were recorded including probing 
depth (PD) and bleeding on probing (BOP). The mean levels of PGE2, LTB4, and MMP-9 
were significantly (P<0.05) higher in GCF from Down syndrome patients compared to 
controls. When comparing the two groups, the correlation coefficients for LTB4 to BOP and 
PD, respectively, as well as for MMP-9 to BOP significantly differed between Down 
syndrome and controls (P<0.05).  
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4.3.2 Studies investigating degrading enzymes 
Halinen et al. (1996) characterized the periodontal status of 9 non-institutionalized DS 
children 9 to 17 years old relative to their age-matched systemically and periodontally 
healthy controls. Clinical periodontal parameters were recorded. They also assessed the 
collagenase and gelatinase activities in the gingival crevicular fluid (GCF) and saliva 
samples collected from DS patients and from the controls. The endogenously active 
collagenase and total collagenase activities were slightly higher in GCF of DS children 
compared to healthy controls. Western blot demonstrated that GCF collagenase of DS 
patients was human neutrophil collagenase (MMP-8 or collagenase-2). Salivary collagenase 
in DS was high when compared to controls but of the same MMP-8 type as in control saliva. 
Komatsu et al. (2001) examined both the amount present and the enzyme activity of matrix 
metalloproteinases (MMP-2) in the gingival tissues of Down syndrome patients and 
controls. The authors reported that there was a significantly higher production of MMP-2 in 
the cultured gingival fibroblasts of the Down syndrome patients when compared with the 
controls.  In addition, the mRNA expressions of membrane-type I metalloproteinases (MTI-
MMP) and MMP-2 were markedly different when the cultured fibroblasts of the DS patients 
were compared to the controls.  This would indicate that the increased amount of active 
MMP-2 produced in DS could be linked to the simultaneous expression of MTI-MMP, which 
could also be connected to the cause of periodontal disease that is seen in a majority of DS 
patients. 
Yamazaki-Kubota et al. (2010) investigated levels of matrix metalloproteinase-2 (MMP-2) 
and matrix metalloproteinase-8 (MMP-8) in gingival crevicular fluid (GCF) and detection of 
periodontopathic bacteria from subgingival plaque. Samples of GCF and plaque were 
isolated from central incisors. Levels of MMPs were evaluated by enzyme-linked 
immunosorbent assay, and periodontopathic bacteria were detected by polymerase chain 
reaction. Levels of MMP-2 and MMP-8 in DS patients were higher than those in healthy 
control subjects. In the DS group, increases in these MMPs were observed in GCF from 
patients with good oral hygiene and absence of bleeding on probing. The detection rate of 
periodontopathic bacteria in DS patients was higher than that in the control subjects. 
Surprisingly, MMP-2 levels in sites harbouring Porphyromonas gingivalis or Aggregatibacter 
(Actinobacillus) actinomycetemcomitans were lower than in those without these 
microorganisms. 
The cited studies indicate increased matrix metalloproteinase activity in the gingival tissues 
of DS individuals. The presence of MMP-8 suggests that neutrophils in their frustration to 
reach their target pathogens release their enzymes extracellularly. Matrix metalloproteinases 
are involved in the breakdown of the extracellular matrix. Their increased activity in the 
gingival tissues of DS individuals explains the gingival tissue loss and associated clinical 
signs (increased probing depth and loss of attachment) described. In addition the increased 
levels of prostaglandin E2 in combination with increased activity of MMP-9 suggests 
increased osteoclastic activity and explains the increased alveolar bone loss described in DS 
individuals. 
5. A hypothesized model of the pathogenesis of periodontitis in Down 
syndrome 
The presented articles viewed collectively suggest the following sequence of events in the 
pathogenesis of periodontitis in DS. Decreased salivary flow accompanied by reduced 
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salivary antibody production and defective neutrophil chemotaxis facilitates early microbial 
colonization in the dentogingival region and makes it easier for periodontal pathogens to 
gain a foothold. The heavy microbial presence initiates a strong gingival 
immune/inflammatory response characterized by the presence of high numbers of 
macrophages and lymphocytes in the gingival tissues. Antigen presenting cells are active in 
initiating adaptive immunity (as evidenced by the increased expression of HLA Class II 
antigens on inflammatory cells) and eventually the production of a strong humoral antibody 
response. The specific antibodies may help with containing the microbial infection. In 
addition, macrophages and other gingival resident cells (fibroblasts) seem to be engaged in 
high production of degrading enzymes. Frustrated neutrophils may release their degrading 
enzymes extracellularly into the gingival tissues. Tissue injury releases arachidonic acid 
metabolites (prostaglandins). The degrading enzymes and prostaglandins are involved with 
periodontal tissue destruction (figure 3). 
 
 
 
 
 
 
 
Fig. 3. Hypothesized model of periodontitis pathogenesis in Down syndrome. 
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6. Conclusions 
In summary I have attempted to use the available periodontal literature on periodontitis in 
DS to construct a hypothesized model of the pathogenesis of the disease. Periodontitis in DS 
individuals is characterized by an intense and persistent immune/inflammatory response. 
Viewing this body of literature as a temporal sequence of events suggests that therapies 
aiming at reduction of microbial colonization could greatly benefit DS individuals by 
reducing the immune/inflammatory response and associated inflammatory mediators and 
degrading enzymes. The model also may suggest future therapies such as host response 
modulation. Strikingly absent from the model is information related to core 
immune/inflammatory abnormalities associated with DS such as increased oxidative stress, 
altered integrin expression (and associated altered lymphocyte function), altered IL-10 
receptor expression (and possible impact on resolution of inflammation), and increased IL-1 
production and their relation to periodontal disease. Further studies are needed to resolve 
these gaps in knowledge, and to access the implications for everyday periodontal care of 
this periodontally vulnerable population. 
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